Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma. [electronic resource]
Producer: 20130319Description: 207-15 p. digitalISSN:- 1365-2141
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bendamustine Hydrochloride
- Cell Cycle Checkpoints -- drug effects
- Combined Modality Therapy
- DNA Repair -- drug effects
- Disease-Free Survival
- Drug Evaluation
- Female
- Hematologic Diseases -- chemically induced
- Hematopoietic Stem Cell Transplantation
- Hodgkin Disease -- drug therapy
- Humans
- Male
- Middle Aged
- Nitrogen Mustard Compounds -- adverse effects
- Off-Label Use
- Recurrence
- Retrospective Studies
- Salvage Therapy
- Transplantation, Homologous
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.